Table 2.
Comparison of socio-demographic and clinical variables of OCD patients with vs without clinical worsening during the second wave of COVID-19.
| Patients with OW | Patients without OW | |
|---|---|---|
| N (%) | 43(37.1%) | 73(62.9%) |
| Sex (M;F) | 19(44.2%); 24(55.8%) | 44(60.3%); 29(39.7%) |
| Mean age (years) | 44.58 ± 13.43* | 36.95 ± 12.79 |
| Pharmacological Stability | 15(34.9%)** | 60(82.2%) |
| Need for Pharmacological Adjustment | 32(74.4%)** | 7(9.6%) |
| Psychiatric Comorbidity | 32(74.4%)^ | 39(53.4%) |
| New obsessions development | 17(39.5%)** | 3(4.1%) |
| Past obsessions occurrence | 26(60.5%)** | 3(4.1%) |
| New Compulsions development | 15(34.9%)** | 1(1.4%) |
| Past Compulsions occurrence | 22(51.2%)** | 2(2.7%) |
| Suicidal ideation | 5(11.6%)^ | 2(2.7%) |
| Internet Checking | 23(53.5%) | 26(35.6%) |
| Family Accommodation increase | 27(62.8%)** | 11(15.1%) |
| Avoidance behaviors increase | 35(81.4%)** | 12(16.4%) |
| Sleep disturbances | 26(60.5%)** | 11(15.1%) |
| Working | 22(51.2%) | 46(63%) |
| Smartworking | 6(14%)* | 30(41.1%) |
| Job difficulties | 16(37.2%)* | 10(13.7%) |
Notes: Values for categorical and continuous variables are expressed in percentages and mean ± SD, respectively. OW: OCD Worsening. Boldface indicates significant differences between subgroups; **p < 0.001 *p < 0.005 ^p < 0.05.